The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Abukhaltam Akhmad D.A.

Pirogov Russian National Research Medical University

Polesko I.V.

The Russian National Research Medical University named after N.I. Pirogov

Khaldin A.A.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Kim D.G.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Tsygankova E.I.

Pirogov Russian National Research Medical University;
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Modern methods of treatment of latent form of HPV infection: clinical observation

Authors:

Abukhaltam Akhmad D.A., Polesko I.V., Khaldin A.A., Kim D.G., Tsygankova E.I.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2025;24(4): 425‑429

DOI: 10.17116/klinderma202524041425

Read: 469 times

Buy for 300₽
Contact the author
Table of contents

MODERN METHODS OF TREATMENT OF LATENT FORM OF HPV INFECTION: CLINICAL OBSERVATION
MODERN METHODS OF TREATMENT OF LATENT FORM OF HPV INFECTION: CLINICAL OBSERVATION

To cite this article:

Abukhaltam Akhmad DA, Polesko IV, Khaldin AA, Kim DG, Tsygankova EI. Modern methods of treatment of latent form of HPV infection: clinical observation. Russian Journal of Clinical Dermatology and Venereology. 2025;24(4):425‑429. (In Russ.)
https://doi.org/10.17116/klinderma202524041425

 
Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Improvement of therapy of papi­llomavirus infe­ction latent forms. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):575-580
From atopy to infe­ction — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):430-436
Anogenital warts: from the problems of epidemiological record to the proven effect of vaccine prophylaxis on popu­lation health as a marker of global success in the fight against HPV. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):504-510
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117
Features of the clinical course of biological subtypes of squamous cell oropharyngeal carcinoma. P.A. Herzen Journal of Onco­logy. 2025;(1):58-62
Comparative analysis of morphometric and histological characteristics of HPV-associated and HPV-independent vulvar squamous cell carcinoma. Russian Journal of Archive of Pathology. 2025;(3):26-32
Influence of carriage of papi­llomavirus infe­ction on the course of exte­rnal geni­tal endo­metriosis in patients with intraepithelial lesion of the cervix. Russian Journal of Human Reproduction. 2025;(3):77-83
Abstract:

Papillomavirus infection is one of the most common urogenital tract infections with pronounced oncogenic potential. Human papillomavirus (HPV) is associated with the development of cancer of uterine cervix, vagina, vulva, penis and oropharyngeal neoplasms. Despite the fact that anogenital warts are the main clinical manifestation of the infection, a significant number of cases is latent, that complicates diagnosis and early treatment. The article presents a clinical observation of a 25-year-old patient with latent form of papillomavirus infection. PCR testing revealed HPV of 6, 11, 39, 59 and 56 genotypes, including high-risk oncogenic types with no visible clinical manifestations. The patient was treated with recombinant interferon alpha-2b in combination with antioxidants. The control examination 4 weeks after the end of treatment showed complete elimination of the pathogen, that indicates the selected therapy’s efficacy. The mechanism of action of interferon alpha-2b is realized through activation of cellular and humoral immunity, suppression of viral replication and enhancement of phagocyte activity of macrophages. The inclusion of antioxidants (vitamins C and E) potentiates antiviral activity by stabilizing cellular membranes. The presented observation confirms that immunomodulatory therapy using recombinant interferons in combination with antioxidants is an effective method for treatment of latent HPV infection, providing elimination of the causative agent and reducing the risk of developing HPV-associated cancers.

Keywords:

papillomavirus infection
latent papillomavirus infection
human papillomavirus
clinical observation
interferon alpha-2b

Authors:

Abukhaltam Akhmad D.A.

Pirogov Russian National Research Medical University

Polesko I.V.

The Russian National Research Medical University named after N.I. Pirogov

Khaldin A.A.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Kim D.G.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Tsygankova E.I.

Pirogov Russian National Research Medical University;
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Received:

21.03.2025

Accepted:

04.06.2025

Close metadata

References:

  1. Park IU, Introcaso C, Dunne EF. Human Papillomavirus and Genital Warts IlI A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin. Infect. Dis. 2015;IlIG1(8):S849-855.  https://doi.org/10.1093/cid/civ813
  2. Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2021;8:552028. https://doi.org/10.3389/fpubh.2020.552028
  3. O’Mahony C, Gomberg M, Skerlev M, Alraddadi A, de Las Heras-Alonso ME, Majewski S, Nicolaidou E, Serdaroğlu S, Kutlubay Z, Tawara M, Stary A, Al Hammadi A, Cusini M. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6): 1006-1019. https://doi.org/10.1111/jdv.15570
  4. Steben M, Garland SM. Genital warts. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1063-1073. https://doi.org/10.1016/j.bpobgyn.2014.07.002
  5. Kim DG, Khaldin AA. Experience of recombinant interferon alpha-2b and antioxidants usage in patients with positive HPV screening results. Russian Journal of Clinical Dermatology and Venereology. 2021;20(5):66-72. (In Russ.). https://doi.org/10.17116/klinderma20212005166
  6. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens — Part B: biological agents. Lancet Oncol. 2009;10(4):321-322.  https://doi.org/10.1016/s1470-2045(09)70096-8
  7. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000;92:709-720.  https://doi.org/10.1093/jnci/92.9.709
  8. Frazer IH. Interaction of human papillomaviruses with the host immune system: A well evolved relationship. Virology. 2009;384:410-414.  https://doi.org/10.1016/j.virol.2008.10.004
  9. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123-137.  https://doi.org/10.1093/aje/kwn036
  10. Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmerón J, Chow SN, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Paavonen J, Bozonnat MC, Descamps D, Struyf F, Dubin GO, Rosillon D, Baril L.; HPV PATRICIA Study Group. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One. 2013;8(11):e79260. Erratum in: PLoS One. 2013;8(12). https://doi.org/10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a
  11. Oh HY, Kim MK, Seo S, Lee DO, Chung YK, Lim MC, Kim J, Lee CW, Park S. Alcohol consumption and persistent infection of high-risk human papillomavirus. Epidemiol. Infect. 2015;143:1442-1450. https://doi.org/10.1017/S0950268814002258
  12. Shanmugasundaram S, You J. Targeting Persistent Human Papillomavirus Infection. Viruses. 2017;9(8):229.  https://doi.org/10.3390/v9080229
  13. Bernal-Silva S, Granados J, Gorodezky C, Aláez C, Flores-Aguilar H, Cerda-Flores RM, Guerrero-González G, Valdez-Chapa LD, Morales-Casas J, González-Guerrero JF, Barrera-Saldaña H.A. HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study. Infect Agent Cancer. 2013;8(1):31.  https://doi.org/10.1186/1750-9378-8-31
  14. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J. Infect. Dis. 2001;184: 1508-1517. https://doi.org/10.1086/324579
  15. Ibishev KhS, Lapteva TO, Krakhotkin DV, Ryabenchenko NN. The role of papillomavirus infection in the development of recurrent lower urinary tract infection. Urologiya. 2019;5:136-139. (In Russ.). https://doi.org/10.18565/urology.2019.5.136-139
  16. Bairamova GR, Baranov II, Dobrovol’skaya DA, Pronina VA, Andreev AO, Malinovskaya. VV, Shuvalov AN. Anogenital warts: a modern view of the problem. Doktor.Ru. 2021;20(8):28-35. (In Russ.). https://doi.org/10.31550/1727-2378-2021-20-8-28-35
  17. Abukhaltam Akhmad DA, Polesko IV, Khaldin AA, Kim DG. Improvement of therapy of papillomavirus infection latent forms. Russian Journal of Clinical Dermatology and Venereology. 2024;23(5):575-580. (In Russ.). https://doi.org/10.17116/klinderma202423051575
  18. La Torre G, de Waure C, Chiaradia G, Mannocci A, Ricciardi W. HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis. Vaccine. 2007;25:8352-8358. https://doi.org/10.1016/j.vaccine.2007.09.027
  19. Borovikov IO, Kutsenko II, Gorring KhI. Vaccination in latent forms of papillomavirus infection: an experimental randomized prospective open-label controlled trial. Kubanskii nauchnyi meditsinskii vestnik. 2024;31(4):30-41. (In Russ.). https://doi.org/10.25207/1608-6228-2024-31-4-30-41
  20. Raevskaya NM, Nikitina TN, Simbirtsev AS, Soloveva IL, Volgin AR, Korovkin AS. Prospectives of developing therapeutic HPV vaccines. Russian Journal of Infection and Immunity = Infektsiya i immunitet. 2024;14(4): 655-671. (In Russ.). https://doi.org/10.15789/2220-7619-POD-17636
  21. Van der Burg SH, Arens R, Melief CJM. Immunotherapy for persistent viral infections and associated disease. Trends Immunol. 2011;32:97-103.  https://doi.org/10.1016/j.it.2010.12.006
  22. Kravchenko EN, Kudymova TN, Lisitsa EV, Ul’yanova IO. The use of interferon-alpha 2b in the treatment of viral and concomitant infections in gynecology, prevention of complications, relapses and rehabilitation. Literaturnyi obzor. Mat’ i ditya v Kuzbasse. 2024;1(96):73-81. (In Russ.). https://doi.org/10.24412/2686-7338-2024-1-73-81
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.